Trial

NCT01738243

Hyaluronic Acid Gels for Upper Lid Retraction in Active Stage Thyroid Eye Disease
Phase IVTERMINATEDOPERATIONALConfidence: HIGH
Sponsor
University of California, Los Angeles
Collaborators
Condition
Thyroid Eye Disease
Intervention
Hyaluronic Acid Gel injection
Why stopped
recruitment challenges
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2021-10-04